🔎 Trials Near Me

Akèy › Kansè pankreyas › Kalifòni › Mountain View

Etid klinik pou Kansè pankreyas nan Mountain View, CA

12 etid pou Kansè pankreyas ap chèche patisipan nan sit nan ak bò kote Mountain View (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Ap rekriteEtid obsèvasyon
  • Stanford University, Palo Alto · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT04981119

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

Ap rekriteFaz 3
  • Stanford Cancer Institute, Palo Alto · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07252232

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Ap rekriteFaz 1/2
  • Stanford Cancer Institute, Stanford · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

Ap rekriteEtid obsèvasyon
  • Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi lwen
Jiska laj 17 · Tout sèks · Mizajou Sep 11, 2026 · NCT06651580

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Ap rekriteFaz 3
  • Palo Alto Medical Foundation-Camino Division, Mountain View
  • Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi lwen
  • Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06958328

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Ap rekriteFaz 1/2
  • Stanford University, Stanford · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT06051695

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Ap rekriteFaz 3
  • Palo Alto Medical Foundation-Camino Division, Mountain View
  • Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
  • Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT06998940

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

Ap rekriteFaz 2
  • Stanford Cancer Center Palo Alto, Stanford · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Apr 3, 2026 · NCT06850623

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Stanford · 5 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions

Ap rekriteEtid obsèvasyon
  • Stanford Hospital, Stanford · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 22, 2025 · NCT03492151

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

Ap rekriteFaz 1/2
  • Stanford Hospital & Clinics, Stanford · 5 mi lwen
Laj 15 ak plis · Tout sèks · Mizajou Aug 12, 2025 · NCT06298916

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

Ap rekriteEtid obsèvasyon
  • Stanford University, Stanford · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Apr 1, 2025 · NCT03260842

Etid Kansè pankreyas nan lòt vil

Lòt etid nan Mountain View

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.